newsfilter
← Latest News
GlobeNewswire·

Avicanna to Report Q3 2026 Results and Host Call on Nov. 12

TORONTO, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Avicanna Inc. ("Avicanna" or the "Company") (TSX:AVCN) (OTCQB:AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and